From June 3 to 7, 2022, the American Society of Clinical Oncology (ASCO) Annual Meeting was grandly held. The ASCO Annual Meeting is one of the most authoritative academic exchange events in the global oncology field. Many international cutting-edge and highly anticipated clinical oncology research findings and clinical data were disclosed.

The GoBroad team, committed to innovation since its establishment in 2017, has reported Chinese scientific research outcomes more than 80 times at top international hematology academic conferences, delivering an impressive report card in the global hematology field. At this event, the team had 2 research projects selected for ASCO2022 poster presentations.